Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Brianna Hanson

Brianna Hanson

Med Learning Group, USA

Title: Innovative CME tools in the teaching of evolving strategies in the management & prevention of COVID 19

Biography

Biography: Brianna Hanson

Abstract

In 2020, Med Learning Group (MLG) launched an interactive, multi-faceted educational initiative focusing on COVID-19. The innovative education & tools developed for FRONTLINE are publicly available for the entire healthcare community to use. Learners range from a variety of specialties, including infectious disease specialists, pulmonary medicine specialists, emergency room practitioners, advanced practitioners, nurses, & other healthcare professionals to help support them in their effort to optimize care of patients with COVID-19. This initiative seeks to reach over 25,000 learners with innovative educational programs & tools to enhance the learning experience, facilitate continuous learning & support the translation of education into practice, & encourage HCP-patient dialogue:

  • COVID Community of Care Website/Application
  • COVID Frontline Update Podcast Series
  • Virtual/Live ECHO Series with 3D animations of pathophysiology
  • Enduring ECHO Module with Case Discussions
  • Quality Improvement Personalized Posters

​By September 2020, we will have the results from pre/posttests, intra-activity Q&A, evaluations, & 60- to 90-day follow-on assessments. We will evaluate learners’ changes in knowledge & competence, & reported practice changes. MLG will have feedback collected via surveys & interviews on the various point-of-care tools. Advanced tools like virtual live learning platforms, mobile websites/apps, 3D animations & podcasts will prove to be an asset to the continuing education of HCPs treating patients with COVID-19. The outcomes are expected to demonstrate the extent to which HCPs have enhanced their ability to identify clinical predictors of disease severity of COVID-19 & apply current treatment guidelines, clinical trial data, & patient-specific factors to the management of patients with COVID-19.